Manufacturer record
Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114 (Himachal Pradesh) was declared Not of Standard Quality in December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MDL-C490, Ranitidine Oral Solution IP ZALTAC Syrup (exp Jul 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per IP 2022 in respect to The test pH and Assay of Ranitidine Hydrochloride calculated as. Listed in the December 2025 alert.
Records by type
1 record linked to Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ranitidine Oral Solution IP ZALTAC Syrup | Batch MDL-C490Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to claim as per IP 2022 in respect to The test pH and Assay of Ranitidine Hydrochloride calculated as Ranitidine.Assay | RDTL, ChandigarhCDSCO lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.